Skip to main content

Table 3 The proportion of patients with increased Hb levels based on the mean of MCV reference value (patients not on iron therapy)

From: Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective study

MCV ≤ 90.9 fL

ΔHb ≤ 0

ΔHb > 0

 

MCV > 90.9 fL

ΔHb ≤ 0

ΔHb > 0

ESA

15 (50%)

15 (50%)

 

ESA

23 (27%)

61 (73%)

HIF-PHI

0 (0%)

18 (100%)

 

HIF-PHI

11 (18%)

51 (82%)

Total

15 (31%)

33 (69%)

 

Total

34 (23%)

112 (77%)

  

P < 0.001

   

P = 0.23